ERGO

Ergo is a biotech startup based in Wilmington, Delaware. The company is a small business with 12 employees and generates $2.5 million in annual revenue. Ergo specializes in the production of animal proteins using plant cell precision fermentation. Their technology allows them to "program" plant cells with multiple genetic modifications, enabling them to produce millions of these cells in bioreactors. This process aims to create plant-based alternatives to animal products that are both organoleptically and nutritionally superior. The company's focus is on producing bovine myoglobin for use in plant-based meat and bovine caseins for plant-based cheeses. Ergo believes their technology has the potential to revolutionize the food industry and contribute to a more sustainable future. For more information about Ergo and their products, visit their website at ergobiotech.com.